Skip to content
  • Tuesday, 29 September 2026
  • 12:24 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • CEPI Fast-Tracks Three Ebola Vaccine Candidates from IAVI, Moderna, and Oxford Amidst Bundibugyo Outbreak in DRC and Uganda
Laboratory Automation & Robotics

CEPI Fast-Tracks Three Ebola Vaccine Candidates from IAVI, Moderna, and Oxford Amidst Bundibugyo Outbreak in DRC and Uganda

Lana Keisha Jul 12, 2026 0

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the urgent fast-tracking of three investigational vaccine candidates aimed at combating…

Read More
Laboratory Automation & Robotics

CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna, and Oxford

Lana Keisha Jul 1, 2026 0

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced a critical initiative to accelerate the development of three investigational vaccines…

Read More
Laboratory Automation & Robotics

CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna, and Oxford

Lana Keisha Jun 24, 2026 0

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced a critical initiative to accelerate the development of three investigational vaccines…

Read More
Laboratory Automation & Robotics

CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna and Oxford

Lana Keisha Jun 16, 2026 0

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the urgent fast-tracking of three investigational vaccine candidates aimed at combating…

Read More
Laboratory Automation & Robotics

CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna, and Oxford to Combat Bundibugyo Outbreak

Lana Keisha Jun 5, 2026 0

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the urgent fast-tracking of three investigational vaccine candidates aimed at combating…

Read More
Breakthrough in PFAS Degradation Scientists Identify Hydrogen Radicals as Key to Destroying Forever Chemicals Using UV LightPharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.Small study suggests probiotic yogurt strain may boost immunotherapy response in lung cancerWith genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are drafted.
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
A Century of Chemistry Textbooks Got It Wrong: International Researchers Rewrite the Inductive EffectAstraZeneca Deepens Oncology Footprint with $2bn Equity Investment in Summit Therapeutics to Advance Next-Generation Cancer CombinationsThe Deep End Talk to Me podcast season explores the intersection of human identity and voice restoration technologyTop 5 Free Open-Source Courses to Master AI Engineering in 2026
YOU MAY HAVE MISSED
Advanced Materials Science
A Century of Chemistry Textbooks Got It Wrong: International Researchers Rewrite the Inductive Effect
Nila Kartika Wati Sep 29, 2026
Pharmaceutical R&D
AstraZeneca Deepens Oncology Footprint with $2bn Equity Investment in Summit Therapeutics to Advance Next-Generation Cancer Combinations
Teuku Ryan Sep 29, 2026
Environmental & Analytical Chemistry
The Deep End Talk to Me podcast season explores the intersection of human identity and voice restoration technology
Abdurrohim Arsyad Sep 29, 2026
Data Science & Bioinformatics
Top 5 Free Open-Source Courses to Master AI Engineering in 2026
Evan Lee Salim Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ